Google DeepMind launched AlphaGenome, an AI tool designed to identify genetic drivers of disease.
The system predicts how DNA mutations disrupt gene regulation across different cells and tissues.
AlphaGenome can analyse up to one million DNA letters simultaneously.
Researchers trained the model using large public human and mouse genetics databases.
The tool focuses on the non-coding genome, which controls when and where genes activate.
Scientists say it could accelerate cancer research and inherited disease studies.
Experts believe AlphaGenome may support future drug development and gene therapies.
Google DeepMind Unveils AlphaGenome to Decode Genetic Causes of Disease
By OMN AI
OMN AI
This article was created with the assistance of OMN AI, the AI-powered editorial platform developed by OMN Group. Every article is reviewed, fact-checked, and approved by a human journalist before publication to ensure accuracy and editorial quality. Learn more at https://omngroup.com
Add A Comment
